BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torre‐cisneros J, Doblas A, Aguado J, San Juan R, Blanes M, Montejo M, Cervera C, Len O, Carratala J, Cisneros J, Bou G, Muñoz P, Ramos A, Gurgui M, Borrell N, Fortún J, Moreno A, Gavalda J; Spanish Network for Research in Infectious Diseases. Tuberculosis after Solid‐Organ Transplant: Incidence, Risk Factors, and Clinical Characteristics in the RESITRA (Spanish Network of Infection in Transplantation) Cohort. CLIN INFECT DIS 2009;48:1657-65. [DOI: 10.1086/599035] [Cited by in Crossref: 182] [Cited by in F6Publishing: 191] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Katrak S, Han E, Readhead A, Fung M, Keh C, Flood J, Barry P. Solid organ transplant recipients with tuberculosis disease in California, 2010 to 2020. Am J Transplant 2022:S1600-6135(22)29290-9. [PMID: 36695700 DOI: 10.1016/j.ajt.2022.11.019] [Reference Citation Analysis]
2 Doblas A, Torre-Cisneros J. The role of alternative regimens in the management of tuberculosis in transplant recipients: From past challenges to future opportunities. Transpl Infect Dis 2022;24:e13958. [PMID: 36468202 DOI: 10.1111/tid.13958] [Reference Citation Analysis]
3 Radisic MV, Pujato NR, Bravo PM, Del Grosso RC, Hunter M, Beltramino S, Linares González L, Cornet ML, Del Carmen Rial M, Franzini RL, Dotta AC, León LR, Walther J, Uva PD, Werber G. Tuberculosis treatment without rifampin in kidney/kidney-pancreas transplantation: A case series report. Transpl Infect Dis 2022;24:e13949. [PMID: 36515463 DOI: 10.1111/tid.13949] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Schaberg T, Brinkmann F, Feiterna-sperling C, Geerdes-fenge H, Hartmann P, Häcker B, Hauer B, Haas W, Heyckendorf J, Lange C, Maurer FP, Nienhaus A, Otto-knapp R, Priwitzer M, Richter E, Salzer HJ, Schoch O, Schönfeld N, Stahlmann R, Bauer T. Tuberkulose im Erwachsenenalter. Pneumologie 2022;76:727-819. [DOI: 10.1055/a-1934-8303] [Reference Citation Analysis]
5 Vargas Barahona L, Henao-Cordero J, Smith J, Gray A, Marshall CB, Scherger S, Bajrovic V, Koullias Y. Disseminated tuberculosis in a lung transplant recipient presenting as tenosynovitis, subcutaneous nodules, and liver abscesses. Ther Adv Infect Dis 2022;9:20499361221132153. [PMID: 36311553 DOI: 10.1177/20499361221132153] [Reference Citation Analysis]
6 Sorohan BM, Ismail G, Tacu D, Obrișcă B, Ciolan G, Gîngu C, Sinescu I, Baston C. Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive Review. Pathogens 2022;11:1041. [DOI: 10.3390/pathogens11091041] [Reference Citation Analysis]
7 Mauricio C, Angélica FE, de Jesús AA, Rodrigo TJ, Aldo C, Ignacio CJ, Jorge A. Disseminated Histoplasmosis, Pulmonary Tuberculosis, and Cytomegalovirus Disease in a Renal Transplant Recipient after Infection with SARS-CoV-2. Case Reports in Transplantation 2022;2022:1-5. [DOI: 10.1155/2022/8042168] [Reference Citation Analysis]
8 Waller KMJ, De La Mata NL, Wyburn KR, Hedley JA, Rosales BM, Kelly PJ, Ramachandran V, Shah KK, Morton RL, Rawlinson WD, Webster AC. Notifiable Infectious Diseases Among Organ Transplant Recipients: A Data-Linked Cohort Study, 2000–2015. Open Forum Infectious Diseases 2022;9:ofac337. [DOI: 10.1093/ofid/ofac337] [Reference Citation Analysis]
9 Maanaoui M, Hazzan M, Glowacki F, Hénon F, Bouyé S. Contre-indications temporaires à la transplantation rénale : sécuriser l’accès à la greffe. La Presse Médicale Formation 2022. [DOI: 10.1016/j.lpmfor.2022.07.006] [Reference Citation Analysis]
10 Alemu A, Bitew ZW, Diriba G, Seid G, Eshetu K, Chekol MT, Berhe N, Gumi B. Tuberculosis incidence in patients with chronic kidney disease: a systematic review and meta-analysis. Int J Infect Dis 2022;122:188-201. [PMID: 35609860 DOI: 10.1016/j.ijid.2022.05.046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cooper R, Houston S, Hughes C, Johnston JC. Chapter 10: Treatment of active tuberculosis in special populations. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 2022;6:149-166. [DOI: 10.1080/24745332.2022.2039500] [Reference Citation Analysis]
12 Varughese S, Sahay M, Shah D, Nagvekar V, Jha V. Evaluation and management of tuberculosis in solid organ transplant recipients: South Asian expert group opinion. Indian J Transplant 2022;16:15. [DOI: 10.4103/ijot.ijot_18_22] [Reference Citation Analysis]
13 Rashid HU, Begum NAS, Kashem TS. Mycobacterial infections in solid organ transplant recipients. Korean J Transplant 2021;35:208-17. [DOI: 10.4285/kjt.21.0033] [Reference Citation Analysis]
14 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 DeFreitas MR, McAdams HP, Azfar Ali H, Iranmanesh AM, Chalian H. Complications of Lung Transplantation: Update on Imaging Manifestations and Management. Radiol Cardiothorac Imaging 2021;3:e190252. [PMID: 34505059 DOI: 10.1148/ryct.2021190252] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Kwon DE, Han SH, Han KD, La Y, Lee KH. Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country. Transpl Infect Dis 2021;23:e13729. [PMID: 34505751 DOI: 10.1111/tid.13729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Anand P. Neurologic Infections in Patients on Immunomodulatory and Immunosuppressive Therapies. Continuum (Minneap Minn) 2021;27:1066-104. [PMID: 34623105 DOI: 10.1212/CON.0000000000000985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Nasir N, Sarfaraz S, Khanum I, Ansari T, Nasim A, Dodani SK, Luxmi S. Tuberculosis in Solid Organ Transplantation: Insights from TB Endemic Areas. Curr Infect Dis Rep 2021;23. [DOI: 10.1007/s11908-021-00756-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Malinis M, Koff A. Mycobacterium tuberculosis in solid organ transplant donors and recipients. Curr Opin Organ Transplant 2021;26:432-9. [PMID: 34074939 DOI: 10.1097/MOT.0000000000000885] [Reference Citation Analysis]
20 Babar ZU, Nasim A, Kumar S, Nazmi J, Badlani S, Nadeem A, Aziz T. A case series of multidrug-resistant tuberculosis in renal transplant recipients: Challenges in management from a TB endemic country. Transpl Infect Dis 2021;:e13659. [PMID: 34057810 DOI: 10.1111/tid.13659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Friedman DZP, Doucette K. Mycobacteria: Selection of Transplant Candidates and Post-lung Transplant Outcomes. Semin Respir Crit Care Med 2021;42:460-70. [PMID: 34030207 DOI: 10.1055/s-0041-1727250] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Meinerz G, Silva CKD, Dorsdt DMB, Adames JB, Andrade JP, Ventura PE, Monteiro AA, Pasqualotto AC, Garcia VD, Keitel E. Latent tuberculosis screening before kidney transplantation in the South of Brazil. J Bras Nefrol 2021;43:520-9. [PMID: 33999988 DOI: 10.1590/2175-8239-JBN-2020-0189] [Reference Citation Analysis]
23 Chung H, Kim SH, Jo KW, Shim TS, Park GC, Kim KH, Lee SO, Lee SG. Clinical Characteristics and Risk Factors of Early-Onset Tuberculosis After Liver Transplantation. Transplant Proc 2021;53:1694-9. [PMID: 34016463 DOI: 10.1016/j.transproceed.2021.04.016] [Reference Citation Analysis]
24 Ramírez-Sánchez IC, García K, Nieto-Ríos JF. Multifocal skeletal tuberculosis with mycobacteremia after kidney transplantation: A case report. Transpl Infect Dis 2021;:e13591. [PMID: 33655691 DOI: 10.1111/tid.13591] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Dubois M, Dixit A, Lamb G. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Recipients. Glob Pediatr Health 2021;8:2333794X20981548. [PMID: 33506075 DOI: 10.1177/2333794X20981548] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_15] [Reference Citation Analysis]
27 Sangian A, Samavat S, Alahyari S, Nasiri M, Nafar M, Firoozan A, Samadian F, Dalili N, Poorrezagholi F. Agreement between the results of tuberculin skin test and Interferon-Gamma Release Assays in renal transplant candidates. J Res Med Sci 2021;26:88. [DOI: 10.4103/jrms.jrms_708_20] [Reference Citation Analysis]
28 Sasi S, Varghese MK, Nair AP, Hashim S, Al Maslamani M. Tuberculosis in an Allogeneic Transplant Kidney: A Rare Case Report and Review of Literature. Cureus 2020;12:e11661. [PMID: 33391900 DOI: 10.7759/cureus.11661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Trachuk P, Bartash R, Abbasi M, Keene A. Infectious Complications in Lung Transplant Recipients. Lung 2020;198:879-87. [PMID: 33169174 DOI: 10.1007/s00408-020-00403-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
30 Korayem GB, Alissa DA, AlSuhaibani NI, AlSwailem GS, AlShammari MA, Yaqoob I, Aljasser DS, Almaghrabi RS. Empiric vs screening-based use of isoniazid for tuberculosis prophylaxis: Safety and effectiveness in lung transplant recipients in Saudi Arabia. Transpl Infect Dis 2021;23:e13473. [PMID: 32978858 DOI: 10.1111/tid.13473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
31 Yang J, Moon S, Kwon M, Huh K, Jung CW. A case of tuberculosis meningitis after allogeneic hematopoietic stem cell transplantation for relapsed Acute Myeloid Leukemia. Transpl Infect Dis 2021;23:e13482. [PMID: 33012077 DOI: 10.1111/tid.13482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
32 Cheon J, Kim C, Park EJ, Ock M, Lee H, Ahn JJ, Jegal Y, Seo KW, Park SE, Han I, Kang H, An M, Park J, Park GM, Jun JB, Lee T. Active tuberculosis risk associated with malignancies: an 18-year retrospective cohort study in Korea. J Thorac Dis 2020;12:4950-9. [PMID: 33145069 DOI: 10.21037/jtd.2020.02.50] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Shu CC, Tsai MK, Lin SW, Wang JY, Yu CJ, Lee CY. Latent Tuberculosis Infection Increases in Kidney Transplantation Recipients Compared With Transplantation Candidates: A Neglected Perspective in Tuberculosis Control. Clin Infect Dis 2020;71:914-23. [PMID: 32620949 DOI: 10.1093/cid/ciz851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
34 Solé A, Part-lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin. Archivos de Bronconeumología 2020;56:493-8. [DOI: 10.1016/j.arbres.2019.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Solé A, Part-lopez M, Saez B, Laporta R, Anguera G, Cuesta VM, De Pablo A, Canyada-martinez AJ, Pastor A, Gil A, Caminero JA, Bravo C. Tuberculosis Following Lung Transplantation. A 27-Year Spanish Multicenter Experience. Incidence, Presentation, Prevention and Treatment with Rifampicin. Archivos de Bronconeumología (English Edition) 2020;56:493-498. [DOI: 10.1016/j.arbr.2019.10.017] [Reference Citation Analysis]
36 Okamoto K, Santos CAQ. Management and prophylaxis of bacterial and mycobacterial infections among lung transplant recipients. Ann Transl Med 2020;8:413. [PMID: 32355857 DOI: 10.21037/atm.2020.01.120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Berger GN, Pagalilauan GL. Infections in the Adult Solid Organ Transplant Recipient. Primary Care of the Solid Organ Transplant Recipient 2020. [DOI: 10.1007/978-3-030-50629-2_8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Cuéllar-rodríguez J. Evaluaciones y medidas pretrasplante para prevención de infecciones. Revista Mexicana de Trasplantes 2020;9:44-52. [DOI: 10.35366/93485] [Reference Citation Analysis]
39 Pasero D, Lees NJ, Costamagna A, Ellena M, Montrucchio G, Brazzi L. Postoperative Complications and Management. Thoracic Surgery 2020. [DOI: 10.1007/978-3-030-40679-0_81] [Reference Citation Analysis]
40 Wang J, Zhou X, Han C, Wang M, Hu H. Prevalence of invasive aspergillosis in suspected pulmonary tuberculosis at a referral tuberculosis hospital in Shandong, China. Epidemiol Infect 2020;148:e275. [DOI: 10.1017/s095026882000268x] [Reference Citation Analysis]
41 Subramanian AK. Mycobacterium tuberculosis in Transplantation. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_15-1] [Reference Citation Analysis]
42 Abad CL, Razonable RR. Prevention and treatment of tuberculosis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2020;18:63-73. [PMID: 31826668 DOI: 10.1080/14787210.2020.1704255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
43 Scemla A, Manda V. Infectious complications after kidney transplantation. Nephrol Ther 2019;15 Suppl 1:S37-42. [PMID: 30981394 DOI: 10.1016/j.nephro.2019.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Coşkun F, Sakarya M, Selimoğlu K, Dündar HZ, Kıyıcı M, İşçimen R, Yesilbursa D, Kaya E. KARACİĞER NAKİL HASTALARINDA LATENT TÜBERKÜLOZ TEDAVİ YAKLAŞIMI: BURSA ULUDAĞ ÜNİVERSİTESİ DENEYİMİ. Uludağ Üniversitesi Tıp Fakültesi Dergisi 2019. [DOI: 10.32708/uutfd.622962] [Reference Citation Analysis]
45 Behr MA, Edelstein PH, Ramakrishnan L. Is Mycobacterium tuberculosis infection life long? BMJ 2019;367:l5770. [PMID: 31649096 DOI: 10.1136/bmj.l5770] [Cited by in Crossref: 62] [Cited by in F6Publishing: 67] [Article Influence: 15.5] [Reference Citation Analysis]
46 Leong LY, Lin PC, Chi CY, Chou CH, Lu MC, Liao WC, Ho MW, Wang JH, Jeng LB. Risk factors of tuberculosis after liver transplant in a tertiary care hospital. J Microbiol Immunol Infect 2021;54:312-8. [PMID: 31668794 DOI: 10.1016/j.jmii.2019.08.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
47 Abad CLR, Deziel PJ, Razonable RR. Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review. Transpl Infect Dis 2019;21:e13178. [PMID: 31541575 DOI: 10.1111/tid.13178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
48 Welte T, Len O, Muñoz P, Romani L, Lewis R, Perrella A. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response. Infection 2019;47:919-27. [PMID: 31576498 DOI: 10.1007/s15010-019-01360-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
49 Schmidt-Lauber C, Jacobi J, Polifka I, Hilgers KF, Wiesener MS. Suspected colonic cancer turns out to be disseminated tuberculosis in a kidney transplant recipient: A case report. Medicine (Baltimore) 2019;98:e16995. [PMID: 31490381 DOI: 10.1097/MD.0000000000016995] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
50 Silva JT, San-Juan R, Fernández-Ruiz M, Aguado JM. Fluoroquinolones for the treatment of latent Mycobacterium tuberculosis infection in liver transplantation. World J Gastroenterol 2019; 25(26): 3291-3298 [PMID: 31341356 DOI: 10.3748/wjg.v25.i26.3291] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
51 Akyuz F, Cavus B, Iliaz R, Soyer OM, Ormeci A, Evirgen S, Onder S, Koksalan K, Keskin M, Karaca C, Demir K, Gulluoglu M, Cagatay T, Besisik F, Kaymakoglu S. Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy? Eur J Gastroenterol Hepatol 2019;31:777-80. [PMID: 30964811 DOI: 10.1097/MEG.0000000000001403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
52 Gupta RK, Rosenberg G, Eriksen J, Lipman M, Jackson C, Roy A, Zenner D, Smith C, Harber M, Campbell C, Abubakar I. Tuberculosis following renal transplantation in England, Wales and Northern Ireland: a national registry-based cohort study. Eur Respir J 2019;54:1802245. [PMID: 31248953 DOI: 10.1183/13993003.02245-2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
53 Natori Y, Ferreira VH, Nellimarla S, Husain S, Rotstein C, Humar A, Kumar D. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients. Transplantation 2019;103:210-5. [PMID: 29944616 DOI: 10.1097/TP.0000000000002340] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
54 Viana LA, Cristelli MP, Santos DW, Tavares MG, Dantas MTC, Felipe CR, Silva HT, Pestana JM. Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysis. Am J Transplant 2019;19:1421-31. [PMID: 30556285 DOI: 10.1111/ajt.15220] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
55 Fishman JA. Mycobacterium tuberculosis in transplantation: Immunity sufficient to perpetuate disease? Am J Transplant 2019;19:1262-3. [PMID: 30614189 DOI: 10.1111/ajt.15254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
56 Subramanian AK, Theodoropoulos NM; Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant 2019;33:e13513. [PMID: 30817030 DOI: 10.1111/ctr.13513] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
57 Igari H, Akutsu N, Ishikawa S, Aoyama H, Otsuki K, Hasegawa M, Maruyama M, Tsuyuzaki M, Suzuki K, Saigo K. Positivity rate of interferon-γ release assays for estimating the prevalence of latent tuberculosis infection in renal transplant recipients in Japan. J Infect Chemother 2019;25:537-42. [PMID: 30905632 DOI: 10.1016/j.jiac.2019.02.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
58 Maciel MMMD, Ceccato MDG, Carvalho WDS, Navarro PD, Farah KP, Miranda SS. Prevalence of latent Mycobacterium tuberculosis infection in renal transplant recipients. J Bras Pneumol 2018;44:461-8. [PMID: 30726322 DOI: 10.1590/S1806-37562017000000367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
59 Giacomelli IL, Schuhmacher Neto R, Marchiori E, Pereira M, Hochhegger B. Chest X-ray and chest CT findings in patients diagnosed with pulmonary tuberculosis following solid organ transplantation: a systematic review. J Bras Pneumol 2018;44:161-6. [PMID: 29791554 DOI: 10.1590/s1806-37562017000000459] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
60 Kulkarni AP, Sengar M, Chinnaswamy G, Hegde A, Rodrigues C, Soman R, Khilnani GC, Ramasubban S, Desai M, Pandit R, Khasne R, Shetty A, Gilada T, Bhosale S, Kothekar A, Dixit S, Zirpe K, Mehta Y, Pulinilkunnathil JG, Bhagat V, Khan MS, Narkhede AM, Baliga N, Ammapalli S, Bamne S, Turkar S, K VB, Choudhary J, Kumar R, Divatia JV. Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients. Indian J Crit Care Med 2019;23:S64-96. [PMID: 31516212 DOI: 10.5005/jp-journals-10071-23102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Portal-celhay C, Philips JA. Tuberculosis. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_29] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Mccarthy MW, Rosengart A, Walsh TJ. Intracranial, Spinal, and Paraspinal Infections in the Transplant Recipient. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_19] [Reference Citation Analysis]
63 Kowada A. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective. Journal of Infection 2019;78:58-65. [DOI: 10.1016/j.jinf.2018.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
64 Meije Y, Kwak EJ, Aguado JM. Prevention and Treatment of Mycobacterial Infections. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_14] [Reference Citation Analysis]
65 Marriott DJ, Orla Morrissey C. Common Infections Following Lung Transplantation. Essentials in Lung Transplantation 2019. [DOI: 10.1007/978-3-319-90933-2_15] [Reference Citation Analysis]
66 Epstein DJ, Subramanian AK. Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients. Infect Dis Clin North Am. 2018;32:703-718. [PMID: 30146031 DOI: 10.1016/j.idc.2018.05.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
67 Bosch A, Valour F, Dumitrescu O, Dumortier J, Radenne S, Pages-Ecochard M, Chidiac C, Ferry T, Perpoint T, Miailhes P, Conrad A, Goutelle S, Ader F; Lyon TB study Group. A practical approach to tuberculosis diagnosis and treatment in liver transplant recipients in a low-prevalence area. Med Mal Infect. 2019;49:231-240. [PMID: 30591271 DOI: 10.1016/j.medmal.2018.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
68 Giacomelli IL, Schuhmacher Neto R, Nin CS, Cassano PS, Pereira M, Moreira JDS, Nascimento DZ, Hochhegger B. High-resolution computed tomography findings of pulmonary tuberculosis in lung transplant recipients. J Bras Pneumol 2017;43:270-3. [PMID: 29365001 DOI: 10.1590/S1806-37562016000000306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
69 Santoro-Lopes G, Subramanian AK, Molina I, Aguado JM, Rabagliatti R, Len O. Tuberculosis Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018;102:S60-S65. [PMID: 29381579 DOI: 10.1097/tp.0000000000002014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
70 Guirao-arrabal E, Torre-cisneros J. Tuberculin skin test, Interferon gamma release assays or just chest x-ray to study latent tuberculosis before solid organ transplantation? Transpl Infect Dis 2018;20:e12920. [DOI: 10.1111/tid.12920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
71 Dobler CC, Fox GJ, Douglas P, Viney KA, Ahmad Khan F, Temesgen Z, Marais BJ. Screening for tuberculosis in migrants and visitors from high-incidence settings: present and future perspectives. Eur Respir J 2018;52:1800591. [PMID: 29794133 DOI: 10.1183/13993003.00591-2018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
72 Dumas G, Bigé N, Lemiale V, Azoulay E. Patients immunodéprimés, quel pathogène pour quel déficit immunitaire ? (en dehors de l’infection à VIH). Méd Intensive Réa 2018;27:344-366. [DOI: 10.3166/rea-2018-0056] [Reference Citation Analysis]
73 Gras J, De Castro N, Montlahuc C, Champion L, Scemla A, Matignon M, Lachâtre M, Raskine L, Grall N, Peraldi MN, Molina JM. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area. Transpl Infect Dis 2018;20:e12943. [DOI: 10.1111/tid.12943] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
74 Nosotti M, Tarsia P, Morlacchi LC. Infections after lung transplantation. J Thorac Dis 2018;10:3849-68. [PMID: 30069386 DOI: 10.21037/jtd.2018.05.204] [Cited by in Crossref: 42] [Cited by in F6Publishing: 48] [Article Influence: 8.4] [Reference Citation Analysis]
75 Machuca I, Vidal E, de la Torre-cisneros J, Rivero-román A. Tuberculosis in immunosuppressed patients. Enfermedades infecciosas y microbiologia clinica (English ed ) 2018;36:366-374. [DOI: 10.1016/j.eimce.2018.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
76 Cobelens F, Nagelkerke N, Fletcher H. The convergent epidemiology of tuberculosis and human cytomegalovirus infection. F1000Res 2018;7:280. [PMID: 29780582 DOI: 10.12688/f1000research.14184.2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
77 Cobelens F, Nagelkerke N, Fletcher H. The convergent epidemiology of tuberculosis and human cytomegalovirus infection. F1000Res 2018;7:280. [DOI: 10.12688/f1000research.14184.1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Wilmes D, Coche E, Rodriguez-Villalobos H, Kanaan N. Bacterial pneumonia in kidney transplant recipients. Respir Med 2018;137:89-94. [PMID: 29605219 DOI: 10.1016/j.rmed.2018.02.022] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
79 Sayyahfar S, Davoodzadeh F, Hoseini R, Rahimzadeh N, Otukesh H. Comparison of tuberculin skin test and interferon gamma release assay for diagnosis of latent tuberculosis infection in pediatric candidates of renal transplantation. Pediatr Transplant 2018;22. [PMID: 29388291 DOI: 10.1111/petr.13148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
80 Zamora MR. Prevention and Treatment Regimens for Non-viral Infections in the Lung Transplant Recipient. Lung Transplantation 2018. [DOI: 10.1007/978-3-319-91184-7_14] [Reference Citation Analysis]
81 Machuca I, Vidal E, de la Torre-Cisneros J, Rivero-Román A. Tuberculosis in immunosuppressed patients. Enferm Infecc Microbiol Clin (Engl Ed) 2018;36:366-74. [PMID: 29223319 DOI: 10.1016/j.eimc.2017.10.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
82 Schuhmacher Neto R, Giacomelli I, Schuller Nin C, da Silva Moreira J, Comaru Pasqualotto A, Marchiori E, Loureiro Irion K, Hochhegger B. High-resolution CT findings of pulmonary tuberculosis in liver transplant patients. Clinical Radiology 2017;72:899.e9-899.e14. [DOI: 10.1016/j.crad.2017.05.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
83 Pena T, Klesney-Tait J. Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:761-70. [PMID: 29128024 DOI: 10.1016/j.ccm.2017.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
84 Makdisi G, Hooker R, Caldeira C. Pulmonary tuberculous and tuberculous pericardial tamponade post lung transplant. Ann Transl Med 2017;5:308. [PMID: 28856148 DOI: 10.21037/atm.2017.04.43] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Yeo HJ, Cho WH, Kim D, Jeon D, Kim YS. Successful Single-Lung Transplantation in a Patient With a Lung Destroyed by Tuberculosis. Ann Thorac Surg 2017;103:e397-9. [PMID: 28431709 DOI: 10.1016/j.athoracsur.2016.09.095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
86 Aguado JM, Silva JT, Samanta P, Singh N. Tuberculosis and Transplantation. Microbiol Spectr. 2016;4. [PMID: 27809952 DOI: 10.1128/microbiolspec.tnmi7-0005-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
87 McMullan GS, Lewis JH. Tuberculosis of the Liver, Biliary Tract, and Pancreas. Microbiol Spectr 2017;5. [PMID: 28233514 DOI: 10.1128/microbiolspec.TNMI7-0025-2016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
88 Al-mukhaini SM, Al-eid H, Alduraibi F, Hakami HI, Al Talhi H, Shoukri M, Ahmed AM, Ahmed Y, Alrajhi AA. Mycobacterium Tuberculosis in Solid Organ Transplantation: Incidence before and after Expanded Isoniazid Prophylaxis. Ann Saudi Med 2017;37:138-43. [DOI: 10.5144/0256-4947.2017.138] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
89 Sgarabotto D, Fasolato S, Vianello F, Vittadello F, Boccagni P, Ferrarese A, Burra P, Angeli P, Cillo U. Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? Transpl Int. 2017;30:734-736. [PMID: 28332726 DOI: 10.1111/tri.12955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
90 Aguado JM, Tiago Silva J, Samanta P, Singh N. Tuberculosis and Transplantation. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch36] [Reference Citation Analysis]
91 Mcmullan GS, Lewis JH. Tuberculosis of the Liver, Biliary Tract, and Pancreas. Tuberculosis and Nontuberculous Mycobacterial Infections 2017. [DOI: 10.1128/9781555819866.ch27] [Reference Citation Analysis]
92 Makdisi G, Haddad TJ, Makdisi PB, Bittner HB. Tuberculous Empyema Post Bilateral Lung Transplant. Ann Thorac Surg 2017;103:e419-21. [PMID: 28431715 DOI: 10.1016/j.athoracsur.2016.10.071] [Reference Citation Analysis]
93 Chan IHY, Kaushik N, Dobler CC. Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis. Lancet Infect Dis 2017;17:770-9. [PMID: 28410979 DOI: 10.1016/S1473-3099(17)30194-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
94 Huaman MA, Brawley R, Ashkin D. Multidrug-resistant tuberculosis in transplant recipients: Case report and review of the literature. Transpl Infect Dis 2017;19:e12672. [DOI: 10.1111/tid.12672] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
95 Bartoletti M, Martelli G, Tedeschi S, Morelli M, Bertuzzo V, Tadolini M, Pianta P, Cristini F, Giannella M, Lewis RE, Pinna AD, Viale P. Liver transplantation is associated with good clinical outcome in patients with active tuberculosis and acute liver failure due to anti-tubercular treatment. Transpl Infect Dis 2017;19:e12658. [DOI: 10.1111/tid.12658] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
96 Knoll BM, Nog R, Wu Y, Dhand A. Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates. Infection. 2017;45:335-339. [PMID: 28276008 DOI: 10.1007/s15010-017-1004-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
97 Iglesias J, Ledesma KJ, Couto PJ, Liu J. Immune Reconstitution Inflammatory Syndrome Occurring in a Kidney Transplant Patient with Extrapulmonary Tuberculosis. Case Rep Transplant 2017;2017:6290987. [PMID: 28367350 DOI: 10.1155/2017/6290987] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
98 Laghmari M, Thouassa G, Mpando D, Benali SA. Tuberculosis of the Nervous System in Immunocompromised Hosts. Tuberculosis of the Central Nervous System 2017. [DOI: 10.1007/978-3-319-50712-5_35] [Reference Citation Analysis]
99 Kim C, Cordova F, Toyoda Y. Lung Transplantation in Interstitial Lung Disease. Pulmonary Hypertension and Interstitial Lung Disease 2017. [DOI: 10.1007/978-3-319-49918-5_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
100 Bonamonte D, Filoni A, Verni P, Angelini G. Cutaneous Tuberculosis. Mycobacterial Skin Infections 2017. [DOI: 10.1007/978-3-319-48538-6_2] [Reference Citation Analysis]
101 Agarwal SK, Bhowmik D, Mahajan S, Bagchi S. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India. Transpl Infect Dis 2017;19:e12626. [DOI: 10.1111/tid.12626] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
102 Baghban A, Azar MM, Bernardo RM, Malinis M. Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction. BMJ Case Rep 2016;2016:bcr2016217998. [PMID: 27852682 DOI: 10.1136/bcr-2016-217998] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
103 Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016;23:taw058. [PMID: 27625399 DOI: 10.1093/jtm/taw058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
104 Muñoz L, Santin M. Prevention and Management of Tuberculosis in Transplant Recipients: From Guidelines to Clinical Practice. Transplantation 2016;100:1840-52. [DOI: 10.1097/tp.0000000000001224] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
105 Simner PJ, Woods GL, Wengenack NL, Hayden RT, Wolk DM, Carroll KC, Tang Y. Mycobacteria. Microbiol Spectr 2016;4. [DOI: 10.1128/microbiolspec.dmih2-0016-2015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
106 Guirao-Arrabal E, Santos F, Redel-Montero J, Vaquero JM, Cantisán S, Vidal E, Torre-Giménez Á, Rivero A, Torre-Cisneros J. Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use. Transpl Infect Dis 2016;18:512-9. [PMID: 27224905 DOI: 10.1111/tid.12555] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
107 Marmor R, Logan C, Hemming A, Berumen J. Fever, Cough, and Right Lower Quadrant Abdominal Pain in a Liver Transplant Recipient. Am J Transplant 2016;16:1933-5. [DOI: 10.1111/ajt.13772] [Reference Citation Analysis]
108 Simner PJ, Woods GL, Wengenack NL. Mycobacteria. Diagnostic Microbiology of the Immunocompromised Host 2016. [DOI: 10.1128/9781555819040.ch16] [Reference Citation Analysis]
109 Meinerz G, da Silva C, Goldani J, Garcia V, Keitel E. Epidemiology of tuberculosis after kidney transplantation in a developing country. Transpl Infect Dis 2016;18:176-82. [DOI: 10.1111/tid.12501] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
110 Yoo J, Jo K, Kim S, Lee S, Kim JJ, Park S, Lee J, Han DJ, Hwang S, Lee S, Shim TS. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. Transpl Int 2016;29:549-58. [DOI: 10.1111/tri.12752] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
111 European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu. EASL Clinical Practice Guidelines: Liver transplantation. J Hepatol 2016;64:433-85. [PMID: 26597456 DOI: 10.1016/j.jhep.2015.10.006] [Cited by in Crossref: 521] [Cited by in F6Publishing: 528] [Article Influence: 74.4] [Reference Citation Analysis]
112 Sauzullo I, Vullo V, Mastroianni CM. Detecting latent tuberculosis in compromised patients. Curr Opin Infect Dis 2015;28:275-82. [PMID: 25887610 DOI: 10.1097/QCO.0000000000000158] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
113 Sullivan T, Huprikar S. Pneumonia After Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_17] [Reference Citation Analysis]
114 Machado CM. Transplant Infections in Developing Countries. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
115 Pereira M, Gazzoni FF, Marchiori E, Irion K, Moreira J, Giacomelli IL, Pasqualotto A, Hochhegger B. High-resolution CT findings of pulmonary Mycobacterium tuberculosis infection in renal transplant recipients. Br J Radiol 2016;89:20150686. [PMID: 26607644 DOI: 10.1259/bjr.20150686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
116 Meije Y, Piersimoni C, Torre-Cisneros J, Dilektasli AG, Aguado JM; ESCMID Study Group of Infection in Compromised Hosts. Mycobacterial infections in solid organ transplant recipients. Clin Microbiol Infect. 2014;20 Suppl 7:89-101. [PMID: 24707957 DOI: 10.1111/1469-0691.12641] [Cited by in Crossref: 72] [Cited by in F6Publishing: 77] [Article Influence: 9.0] [Reference Citation Analysis]
117 Grim SA, Layden JE, Roth P, Gallitano S, Adams W, Clark NM. Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes. Transpl Infect Dis. 2015;17:768-777. [PMID: 26263530 DOI: 10.1111/tid.12436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
118 Schultz V, Marroni CA, Amorim CS, Baethgen LF, Pasqualotto AC. Risk factors for hepatotoxicity in solid organ transplants recipients being treated for tuberculosis. Transplant Proc. 2014;46:3606-3610. [PMID: 25498098 DOI: 10.1016/j.transproceed.2014.09.148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
119 Pierrotti LC, Kotton CN. Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases. Curr Infect Dis Rep 2015;17:492. [PMID: 26031964 DOI: 10.1007/s11908-015-0492-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
120 Benito N, García-Vázquez E, Horcajada JP, González J, Oppenheimer F, Cofán F, Ricart MJ, Rimola A, Navasa M, Rovira M, Roig E, Pérez-Villa F, Cervera C, Moreno A. Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study. Clin Microbiol Infect 2015;21:651-8. [PMID: 25882369 DOI: 10.1016/j.cmi.2015.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
121 Muñoz L, Gomila A, Casas S, Castellote J, Arnan M, Rafecas A, Santin M. Immunodiagnostic Tests' Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study. Transplant Direct 2015;1:e12. [PMID: 27500217 DOI: 10.1097/TXD.0000000000000520] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
122 Kim SH, Kim MY, Hong SI, Jung J, Lee HJ, Yun SC, Lee SO, Choi SH, Kim YS, Woo JH. Invasive Pulmonary Aspergillosis-mimicking Tuberculosis. Clin Infect Dis 2015;61:9-17. [PMID: 25778752 DOI: 10.1093/cid/civ216] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
123 Torre-Cisneros J, San-Juan R, Rosso-Fernández CM, Silva JT, Muñoz-Sanz A, Muñoz P, Miguez E, Martín-Dávila P, López-Ruz MA, Vidal E, Cordero E, Montejo M, Blanes M, Fariñas MC, Herrero JI, Rodrigo J, Aguado JM. Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial. Clin Infect Dis 2015;60:1642-9. [PMID: 25722196 DOI: 10.1093/cid/civ156] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
124 Bekaoui S, Haddiya I, El Housni S, ElHarraqui R, Rhou H, Benamar L, Eziatouni F, Ouzeddoun N, Bayahia R. [Spinal tuberculosis in renal transplant complicated by systemic fungal infection]. Pan Afr Med J 2014;19:22. [PMID: 25667684 DOI: 10.11604/pamj.2014.19.22.2878] [Reference Citation Analysis]
125 Sidhu A, Verma G, Humar A, Kumar D. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Transplantation. 2014;98:671-675. [PMID: 24825525 DOI: 10.1097/tp.0000000000000133] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
126 Michaels MG, Green MD. Pretransplantation Evaluation. Transplantation of the Liver 2015. [DOI: 10.1016/b978-1-4557-0268-8.00033-6] [Reference Citation Analysis]
127 Sun H. Treating tuberculosis in solid organ transplant recipients. Current Opinion in Infectious Diseases 2014;27:501-5. [DOI: 10.1097/qco.0000000000000102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
128 Ursales A, Klein JA, Beal SG, Koch M, Clement-Kruzel S, Melton LB, Spak CW. Antibiotic failure in a renal transplant patient with Rhodococcus equi infection: an indication for surgical lobectomy. Transpl Infect Dis 2014;16:1019-23. [PMID: 25412764 DOI: 10.1111/tid.12314] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
129 Gutsfeld C, Olaru ID, Vollrath O, Lange C. Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany. PLoS One 2014;9:e112681. [PMID: 25393241 DOI: 10.1371/journal.pone.0112681] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
130 Lee Y, Lee S, Choi S, Kim YS, Woo JH, Kim D, Lee J, Lee J, Lee K, Kim S. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. Journal of Infection 2014;69:165-73. [DOI: 10.1016/j.jinf.2014.02.019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
131 Liu J, Yan J, Wan Q, Ye Q, Huang Y. The risk factors for tuberculosis in liver or kidney transplant recipients. BMC Infect Dis 2014;14:387. [PMID: 25015108 DOI: 10.1186/1471-2334-14-387] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
132 Li XX, Wang LX, Zhang J, Liu YX, Zhang H, Jiang SW, Chen JX, Zhou XN. Exploration of ecological factors related to the spatial heterogeneity of tuberculosis prevalence in P. R. China. Glob Health Action 2014;7:23620. [PMID: 24929074 DOI: 10.3402/gha.v7.23620] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
133 Sun HY, Munoz P, Torre-Cisneros J, Aguado JM, Lattes R, Montejo M, Garcia-Reyne A, Bouza E, Valerio M, Lara R, Wagener MM, John GT, Bruno D, Singh N. Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era. Prog Transplant 2014;24:37-43. [PMID: 24598564 DOI: 10.7182/pit2014398] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
134 Nizami IY, Khan BJ, Saleh W, Hussein M. Successful bilateral lung transplantation from a deceased donor with active Mycobacterium tuberculosis infection. Ann Thorac Surg 2014;97:e109-10. [PMID: 24694450 DOI: 10.1016/j.athoracsur.2013.11.077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
135 Rathi M, Gundlapalli S, Ramachandran R, Mohindra S, Kaur H, Kumar V, Kohli HS, Gupta KL, Sakhuja V. A rare case of Cytomegalovirus, Scedosporium apiospermum and Mycobacterium tuberculosis in a renal transplant recipient. BMC Infect Dis 2014;14:259. [PMID: 24885965 DOI: 10.1186/1471-2334-14-259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
136 Fagiuoli S, Colli A, Bruno R, Craxì A, Gaeta GB, Grossi P, Mondelli MU, Puoti M, Sagnelli E, Stefani S, Toniutto P, Burra P; 2011 AISF Single Topic Group. Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. J Hepatol 2014;60:1075-89. [PMID: 24384327 DOI: 10.1016/j.jhep.2013.12.021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 6.3] [Reference Citation Analysis]
137 Chen C, Shu K, Ho H, Cheng S, Lin C, Wei H, Lin C, Chang S, Wu M. A Nationwide Population-Based Study of the Risk of Tuberculosis in Different Solid Organ Transplantations in Taiwan. Transplantation Proceedings 2014;46:1032-5. [DOI: 10.1016/j.transproceed.2013.10.051] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
138 Fernández-ruiz M, López-medrano F, Allende LM, Andrés A, García-reyne A, Lumbreras C, San-juan R, Morales JM, Paz-artal E, Aguado JM. Kinetics of peripheral blood lymphocyte subpopulations predicts the occurrence of opportunistic infection after kidney transplantation. Transpl Int 2014;27:674-85. [DOI: 10.1111/tri.12321] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 5.9] [Reference Citation Analysis]
139 Ladds E. Disseminated tuberculosis following liver transplant presenting with an axillary abscess. BMJ Case Rep 2014;2014:bcr2013202903. [PMID: 24510698 DOI: 10.1136/bcr-2013-202903] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
140 Vaquero Barrios JM, Redel Montero J, Santos Luna F. Comorbidities Impacting on Prognosis After Lung Transplant. Archivos de Bronconeumología (English Edition) 2014;50:25-33. [DOI: 10.1016/j.arbr.2014.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
141 Vaquero Barrios JM, Redel Montero J, Santos Luna F. Comorbidities impacting on prognosis after lung transplant. Arch Bronconeumol 2014;50:25-33. [PMID: 24355755 DOI: 10.1016/j.arbres.2013.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
142 de Lemos AS, Vieira MA, Halpern M, Quaresma RG, Borchardt AC, Santos MA, Gonçalves RT, Santoro-Lopes G. Results of implementation of preventive recommendations for tuberculosis after renal transplantation in an endemic area. Am J Transplant 2013;13:3230-5. [PMID: 24119248 DOI: 10.1111/ajt.12470] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
143 Rocha A, Lourenço L, Viana L, Taver M, Gaspar M, Medina-Pestana JO. Abdominal tuberculosis following kidney transplantation: clinicopathologic features and follow-up in a unique case series. Clin Transplant 2013;27:E591-6. [PMID: 23924235 DOI: 10.1111/ctr.12210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
144 Horne DJ, Narita M, Spitters CL, Parimi S, Dodson S, Limaye AP. Challenging issues in tuberculosis in solid organ transplantation. Clin Infect Dis. 2013;57:1473-1482. [PMID: 23899676 DOI: 10.1093/cid/cit488] [Cited by in Crossref: 50] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
145 Coll E, Torre-cisneros J, Calvo R, Garrido G, Matesanz R. Incidence of Tuberculosis in Deceased-Organ Donors and Transmission Risk to Recipients in Spain. Transplantation 2013;96:205-10. [DOI: 10.1097/tp.0b013e3182977adf] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
146 Sun HY, Munoz P, Torre-Cisneros J, Aguado JM, Lattes R, Montejo M, Garcia-Reyne A, Bouza E, Valerio M, Lara R. Mycobacterium tuberculosis-associated immune reconstitution syndrome in solid-organ transplant recipients. Transplantation. 2013;95:1173-1181. [PMID: 23435454 DOI: 10.1097/tp.0b013e31828719c8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
147 Rosen J. Travel Medicine and the Solid-Organ Transplant Recipient. Infectious Disease Clinics of North America 2013;27:429-57. [DOI: 10.1016/j.idc.2013.02.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
148 Xie X, Li F, Chen JW, Wang J. Risk of tuberculosis infection in anti-TNF-α biological therapy: From bench to bedside. J Microbiol Immunol Infect. 2013;May 30; [Epub ahead of print]. [PMID: 23727394 DOI: 10.1016/j.jmii.2013.03.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
149 Boillat-Blanco N, Aguado JM, Aubert JD, Sester M, Grossi P, Kamar N, Pascual M, Manuel O; ESCMID Study Group of Infection in Compromised Hosts. European survey on the management of tuberculosis in solid-organ transplant recipients and candidates. Transpl Int. 2013;26:e69-e70. [PMID: 23582103 DOI: 10.1111/tri.12102] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
150 Berger C, Boggian K, Cusini A, van Delden C, Garzoni C, Hirsch HH, Khanna N, Koller M, Manuel O, Meylan P, Nadal D, Weisser M, Mueller NJ; Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant 2012;17:581-5. [PMID: 23111643 DOI: 10.1097/MOT.0b013e328359263a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
151 Küpeli E, Eyüboğlu FÖ, Haberal M. Pulmonary infections in transplant recipients. Curr Opin Pulm Med 2012;18:202-12. [PMID: 22388586 DOI: 10.1097/MCP.0b013e328352104f] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
152 Subramanian AK, Morris MI; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis infections in solid organ transplantation. Am J Transplant 2013;13 Suppl 4:68-76. [PMID: 23465000 DOI: 10.1111/ajt.12100] [Cited by in Crossref: 129] [Cited by in F6Publishing: 133] [Article Influence: 12.9] [Reference Citation Analysis]
153 Marques IDB, Azevedo LS, Pierrotti LC, Caires RA, Sato VAH, Carmo LPF, Ferreira GF, Gamba C, de Paula FJ, Nahas WC, David-neto E. Clinical features and outcomes of tuberculosis in kidney transplant recipients in Brazil: a report of the last decade. Clin Transplant 2013;27:E169-76. [DOI: 10.1111/ctr.12077] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
154 Schneider F, Guillot M, Chomette M, Douiri N, Herbrecht J, Diouf M, Kremer S, Lavigne T, Lutun P. Prise en charge des infections chez les adultes transplantés d’organe(s). Références en réanimation. Collection de la SRLF 2013. [DOI: 10.1007/978-2-8178-0389-0_28] [Reference Citation Analysis]
155 Ha YE, Peck KR. Infection Prevention in Transplant Recipients. Korean J Med 2013;84:168. [DOI: 10.3904/kjm.2013.84.2.168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
156 Hayakawa K, Ramasamy B, Chandrasekar PH. Fever of Unknown Origin: An Evidence-Based Review. The American Journal of the Medical Sciences 2012;344:307-16. [DOI: 10.1097/maj.0b013e31824ae504] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
157 Len Ó, Ramos A, Pahissa A. Evaluating the risk of transmission of infection from donor to recipient of a solid organ transplantation. Enferm Infecc Microbiol Clin 2012;30 Suppl 2:19-26. [PMID: 22542031 DOI: 10.1016/S0213-005X(12)70078-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Doblas A, Alcaide F, Benito N, Gurguí M, Torre-Cisneros J. Tuberculosis in solid organ transplant patients. Enferm Infecc Microbiol Clin. 2012;30 Suppl 2:34-39. [PMID: 22542033 DOI: 10.1016/s0213-005x(12)70080-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
159 Kirsch S, Sester M. Tuberculosis in Transplantation: Diagnosis, Prevention, and Treatment. Curr Infect Dis Rep 2012;14:650-7. [DOI: 10.1007/s11908-012-0293-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
160 Morris MI, Daly JS, Blumberg E, Kumar D, Sester M, Schluger N, Kim SH, Schwartz BS, Ison MG, Humar A, Singh N, Michaels M, Orlowski JP, Delmonico F, Pruett T, John GT, Kotton CN. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant 2012;12:2288-300. [PMID: 22883346 DOI: 10.1111/j.1600-6143.2012.04205.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 9.6] [Reference Citation Analysis]
161 Vecino R, Santiago B, Baquero-artigao F, López GL, García C, Muñoz G, Prieto G, Martínez A, de José MI, Mejías A. Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Pediatric Infectious Disease Journal 2012;31:774-7. [DOI: 10.1097/inf.0b013e3182564ec7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
162 López-Medrano F, Carratalà J, Cruzado JM, Gutiérrez MJ, Aguado JM. Fever in a kidney transplant recipient: no facts and many interactions. Rev Clin Esp 2012;212:193-7. [PMID: 22402372 DOI: 10.1016/j.rce.2011.12.013] [Reference Citation Analysis]
163 Muñoz P, Fernández NS, Fariñas MC. Epidemiology and risk factors of infections after solid organ transplantation. Enfermedades Infecciosas y Microbiología Clínica 2012;30:10-8. [DOI: 10.1016/s0213-005x(12)70077-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
164 Ha Y, Joo E, Park S, Wi Y, Kang C, Chung D, Joh J, Lee S, Song J, Peck K. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients. Transpl Infect Dis 2012;14:626-34. [DOI: 10.1111/j.1399-3062.2012.00721.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
165 Linares L, Sanclemente G, Cervera C, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Marcos MA, Antón A. Influence of cytomegalovirus disease in outcome of solid organ transplant patients. Transplant Proc. 2011;43:2145-2148. [PMID: 21839217 DOI: 10.1016/j.transproceed.2011.05.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]
166 Moreno A, Cervera C, Fortún J, Blanes M, Montejo E, Abradelo M, Len O, Rafecas A, Martín-Davila P, Torre-Cisneros J, Salcedo M, Cordero E, Lozano R, Pérez I, Rimola A, Miró JM; OLT-HIV FIPSE Cohort Investigators. Epidemiology and outcome of infections in human immunodeficiency virus/hepatitis C virus-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transpl 2012;18:70-81. [PMID: 21898772 DOI: 10.1002/lt.22431] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
167 Kariv G, Shani V, Goldberg E, Leibovici L, Paul M. A model for diagnosis of pulmonary infections in solid-organ transplant recipients. Computer Methods and Programs in Biomedicine 2011;104:135-42. [DOI: 10.1016/j.cmpb.2010.06.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
168 Imai S, Ito Y, Hirai T, Imai H, Ito I, Maekawa K, Chin K, Ichiyama S, Uemoto S, Mishima M. Clinical features and risk factors of tuberculosis in living-donor liver transplant recipients. Transplant Infectious Disease 2012;14:9-16. [DOI: 10.1111/j.1399-3062.2011.00680.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
169 Nelson CA, Zunt JR. Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients. Clin Infect Dis 2011;53:915-26. [PMID: 21960714 DOI: 10.1093/cid/cir508] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
170 Kim SH, Lee SO, Park JB, Park IA, Park SJ, Yun SC, Jung JH, Kim YH, Kim SC, Choi SH, Jeong JY, Kim YS, Woo JH, Park SK, Park JS, Han DJ. A prospective longitudinal study evaluating the usefulness of a T-cell-based assay for latent tuberculosis infection in kidney transplant recipients. Am J Transplant 2011;11:1927-35. [PMID: 21749641 DOI: 10.1111/j.1600-6143.2011.03625.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 5.9] [Reference Citation Analysis]
171 Doblas A, Torre-Cisneros J. The current state of tuberculosis in solid organ transplantation: three principles for optimal management. Am J Transplant 2011;11:1769-70. [PMID: 21749642 DOI: 10.1111/j.1600-6143.2011.03626.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
172 Husain S, Mooney ML, Danziger-Isakov L, Mattner F, Singh N, Avery R, Ison M, Humar A, Padera RF, Lawler LP, Fisher A, Drew RJ, Gould KF, Sole A, Studer S, Munoz P, Singer LG, Hannan M; ISHLT Infectious Diseases Council Working Group on Definitions. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011;30:361-74. [PMID: 21419994 DOI: 10.1016/j.healun.2011.01.701] [Cited by in Crossref: 136] [Cited by in F6Publishing: 142] [Article Influence: 11.3] [Reference Citation Analysis]
173 Ersan S, Celik A, Atila K, Aykut Sifil A, Cavdar C, Soylu A, Bora S, Gulay H, Camsari T. Tuberculosis in Renal Transplant Recipients. Renal Failure 2011;33:753-7. [DOI: 10.3109/0886022x.2011.599095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
174 Santín Cerezales M, Navas Elorza E. Tuberculosis in special populations. Enferm Infecc Microbiol Clin 2011;29 Suppl 1:20-5. [PMID: 21420563 DOI: 10.1016/S0213-005X(11)70014-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
175 Batista MV, Pierrotti LC, Abdala E, Clemente WT, Girão ES, Rosa DRT, Ianhez LE, Bonazzi PR, Lima AS, Fernandes PFCBC, Pádua-neto MV, Bacchella T, Oliveira APP, Viana CFG, Ferreira MS, Shikanai-yasuda MA. Endemic and opportunistic infections in Brazilian solid organ transplant recipients: Infections in Brazilian solid organ transplant recipients. Tropical Medicine & International Health 2011;16:1134-42. [DOI: 10.1111/j.1365-3156.2011.02816.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
176 Rajagopala S, Olithselvan A, Varghese J, Shanmugam N, Rela M. Latent Mycobacterium tuberculosis Infection in Liver Transplant Recipients-Controversies in Current Diagnosis and Management. J Clin Exp Hepatol 2011;1:34-7. [PMID: 25755308 DOI: 10.1016/S0973-6883(11)60120-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
177 Dalla Gasperina D, Tozzi M, Astuti N, Balsamo M, Donati D, Rossi A, Dionigi R, Grossi P. Pulmonary Tuberculosis in an HIV- and Hepatitis C Virus–Coinfected Kidney-Pancreas Transplant Recipient: A Case Report. Transplantation Proceedings 2011;43:1206-9. [DOI: 10.1016/j.transproceed.2011.02.050] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
178 Hoyo I, Linares L, Cervera C, Almela M, Marcos MA, Sanclemente G, Cofán F, Ricart MJ, Moreno A. Epidemiology of pneumonia in kidney transplantation. Transplant Proc 2010;42:2938-40. [PMID: 20970576 DOI: 10.1016/j.transproceed.2010.07.082] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
179 Wang X, Zhuang J, Xie L, Li M, Lu Y. Isoniazid preventive therapy for postrenal transplant tuberculosis: a systematic review. Reviews in Medical Microbiology 2011;22:5-11. [DOI: 10.1097/mrm.0b013e3283410434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Luong M, Morrissey O, Husain S. Assessment of infection risks prior to lung transplantation: . Current Opinion in Infectious Diseases 2010;23:578-83. [DOI: 10.1097/qco.0b013e32833f9f93] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
181 Ichai P, Saliba F, Antoun F, Azoulay D, Sebagh M, Antonini TM, Escaut L, Delvart V, Castaing D, Samuel D. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl 2010;16:1136-46. [PMID: 20879012 DOI: 10.1002/lt.22125] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
182 Yehia BR, Blumberg EA. Mycobacterium tuberculosis infection in liver transplantation. Liver Transpl 2010;16:1129-35. [PMID: 20879011 DOI: 10.1002/lt.22133] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
183 Muñoz P, Valerio M, Palomo J, Fernández-yáñez J, Fernández-cruz A, Guinea J, Bouza E. Infectious and Non-Infectious Neurologic Complications in Heart Transplant Recipients. Medicine 2010;89:166-75. [DOI: 10.1097/md.0b013e3181dfa59c] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
184 Holty JE, Sista RR. Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis. Curr Opin Organ Transplant. 2009;14:613-618. [PMID: 19741533 DOI: 10.1097/mot.0b013e3283324dfc] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
185 Subramanian A, Dorman S; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant 2009;9 Suppl 4:S57-62. [PMID: 20070696 DOI: 10.1111/j.1600-6143.2009.02894.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 89] [Article Influence: 6.2] [Reference Citation Analysis]